GW842166X has been used in trials studying the treatment of Pain, Analgesia, Inflammation, Osteoarthritis, and Pain, Inflammatory, among others.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Cocaine | Cocaine may increase the tachycardic activities of GW842166. |
| Trospium | The risk or severity of Tachycardia and drowsiness can be increased when Trospium is combined with GW842166. |
| Oxyphenonium | The risk or severity of Tachycardia and drowsiness can be increased when Oxyphenonium is combined with GW842166. |
| Benzatropine | The risk or severity of Tachycardia and drowsiness can be increased when Benzatropine is combined with GW842166. |
| Disopyramide | The risk or severity of Tachycardia and drowsiness can be increased when Disopyramide is combined with GW842166. |
| Ipratropium | The risk or severity of Tachycardia and drowsiness can be increased when Ipratropium is combined with GW842166. |
| Metixene | The risk or severity of Tachycardia and drowsiness can be increased when Metixene is combined with GW842166. |
| Terfenadine | The risk or severity of Tachycardia and drowsiness can be increased when Terfenadine is combined with GW842166. |
| Buclizine | The risk or severity of Tachycardia and drowsiness can be increased when Buclizine is combined with GW842166. |
| Trihexyphenidyl | The risk or severity of Tachycardia and drowsiness can be increased when Trihexyphenidyl is combined with GW842166. |
| Oxyphencyclimine | The risk or severity of Tachycardia and drowsiness can be increased when Oxyphencyclimine is combined with GW842166. |
| Procyclidine | The risk or severity of Tachycardia and drowsiness can be increased when Procyclidine is combined with GW842166. |
| Profenamine | The risk or severity of Tachycardia and drowsiness can be increased when Profenamine is combined with GW842166. |
| Hyoscyamine | The risk or severity of Tachycardia and drowsiness can be increased when Hyoscyamine is combined with GW842166. |
| Methscopolamine bromide | The risk or severity of Tachycardia and drowsiness can be increased when Methscopolamine bromide is combined with GW842166. |
| Darifenacin | The risk or severity of Tachycardia and drowsiness can be increased when Darifenacin is combined with GW842166. |
| Tridihexethyl | The risk or severity of Tachycardia and drowsiness can be increased when Tridihexethyl is combined with GW842166. |
| Anisotropine methylbromide | The risk or severity of Tachycardia and drowsiness can be increased when Anisotropine methylbromide is combined with GW842166. |
| Atropine | The risk or severity of Tachycardia and drowsiness can be increased when Atropine is combined with GW842166. |
| Nicardipine | The risk or severity of Tachycardia and drowsiness can be increased when Nicardipine is combined with GW842166. |
| Pirenzepine | The risk or severity of Tachycardia and drowsiness can be increased when Pirenzepine is combined with GW842166. |
| Homatropine methylbromide | The risk or severity of Tachycardia and drowsiness can be increased when Homatropine methylbromide is combined with GW842166. |
| Benzquinamide | The risk or severity of Tachycardia and drowsiness can be increased when Benzquinamide is combined with GW842166. |
| Propantheline | The risk or severity of Tachycardia and drowsiness can be increased when Propantheline is combined with GW842166. |
| Dicyclomine | The risk or severity of Tachycardia and drowsiness can be increased when Dicyclomine is combined with GW842166. |
| Biperiden | The risk or severity of Tachycardia and drowsiness can be increased when Biperiden is combined with GW842166. |
| Quinidine | The risk or severity of Tachycardia and drowsiness can be increased when Quinidine is combined with GW842166. |
| Methantheline | The risk or severity of Tachycardia and drowsiness can be increased when Methantheline is combined with GW842166. |
| Cycrimine | The risk or severity of Tachycardia and drowsiness can be increased when Cycrimine is combined with GW842166. |
| Glycopyrronium | The risk or severity of Tachycardia and drowsiness can be increased when Glycopyrronium is combined with GW842166. |
| Tolterodine | The risk or severity of Tachycardia and drowsiness can be increased when Tolterodine is combined with GW842166. |
| Oxybutynin | The risk or severity of Tachycardia and drowsiness can be increased when Oxybutynin is combined with GW842166. |
| Flavoxate | The risk or severity of Tachycardia and drowsiness can be increased when Flavoxate is combined with GW842166. |
| Diphenidol | The risk or severity of Tachycardia and drowsiness can be increased when Diphenidol is combined with GW842166. |
| Tiotropium | The risk or severity of Tachycardia and drowsiness can be increased when Tiotropium is combined with GW842166. |
| Solifenacin | The risk or severity of Tachycardia and drowsiness can be increased when Solifenacin is combined with GW842166. |
| Isopropamide | The risk or severity of Tachycardia and drowsiness can be increased when Isopropamide is combined with GW842166. |
| Mepenzolate | The risk or severity of Tachycardia and drowsiness can be increased when Mepenzolate is combined with GW842166. |
| Fesoterodine | The risk or severity of Tachycardia and drowsiness can be increased when Fesoterodine is combined with GW842166. |
| Hexocyclium | The risk or severity of Tachycardia and drowsiness can be increased when Hexocyclium is combined with GW842166. |
| Dimetindene | The risk or severity of Tachycardia and drowsiness can be increased when Dimetindene is combined with GW842166. |
| Aclidinium | The risk or severity of Tachycardia and drowsiness can be increased when Aclidinium is combined with GW842166. |
| Dexetimide | The risk or severity of Tachycardia and drowsiness can be increased when Dexetimide is combined with GW842166. |
| Umeclidinium | The risk or severity of Tachycardia and drowsiness can be increased when Umeclidinium is combined with GW842166. |
| Trimebutine | The risk or severity of Tachycardia and drowsiness can be increased when Trimebutine is combined with GW842166. |
| Imidafenacin | The risk or severity of Tachycardia and drowsiness can be increased when Imidafenacin is combined with GW842166. |
| Butylscopolamine | The risk or severity of Tachycardia and drowsiness can be increased when Butylscopolamine is combined with GW842166. |
| Thonzylamine | The risk or severity of Tachycardia and drowsiness can be increased when Thonzylamine is combined with GW842166. |
| Methscopolamine | The risk or severity of Tachycardia and drowsiness can be increased when Methscopolamine is combined with GW842166. |
| Revefenacin | The risk or severity of Tachycardia and drowsiness can be increased when Revefenacin is combined with GW842166. |
| Oxitropium | The risk or severity of Tachycardia and drowsiness can be increased when Oxitropium is combined with GW842166. |
| Propiverine | The risk or severity of Tachycardia and drowsiness can be increased when Propiverine is combined with GW842166. |
| Batefenterol | The risk or severity of Tachycardia and drowsiness can be increased when Batefenterol is combined with GW842166. |
| Mebeverine | The risk or severity of Tachycardia and drowsiness can be increased when Mebeverine is combined with GW842166. |
| Tropatepine | The risk or severity of Tachycardia and drowsiness can be increased when Tropatepine is combined with GW842166. |
| Prifinium | The risk or severity of Tachycardia and drowsiness can be increased when Prifinium is combined with GW842166. |
| Piperidolate | The risk or severity of Tachycardia and drowsiness can be increased when Piperidolate is combined with GW842166. |
| Benzilone | The risk or severity of Tachycardia and drowsiness can be increased when Benzilone is combined with GW842166. |
| Difemerine | The risk or severity of Tachycardia and drowsiness can be increased when Difemerine is combined with GW842166. |
| Phenglutarimide | The risk or severity of Tachycardia and drowsiness can be increased when Phenglutarimide is combined with GW842166. |
| Mazaticol | The risk or severity of Tachycardia and drowsiness can be increased when Mazaticol is combined with GW842166. |
| Etybenzatropine | The risk or severity of Tachycardia and drowsiness can be increased when Etybenzatropine is combined with GW842166. |
| Otilonium | The risk or severity of Tachycardia and drowsiness can be increased when Otilonium is combined with GW842166. |
| Poldine | The risk or severity of Tachycardia and drowsiness can be increased when Poldine is combined with GW842166. |
| Bevonium | The risk or severity of Tachycardia and drowsiness can be increased when Bevonium is combined with GW842166. |
| Rociverine | The risk or severity of Tachycardia and drowsiness can be increased when Rociverine is combined with GW842166. |
| Bornaprine | The risk or severity of Tachycardia and drowsiness can be increased when Bornaprine is combined with GW842166. |
| Etanautine | The risk or severity of Tachycardia and drowsiness can be increased when Etanautine is combined with GW842166. |
| Tiemonium iodide | The risk or severity of Tachycardia and drowsiness can be increased when Tiemonium iodide is combined with GW842166. |
| Dihexyverine | The risk or severity of Tachycardia and drowsiness can be increased when Dihexyverine is combined with GW842166. |
| Penthienate | The risk or severity of Tachycardia and drowsiness can be increased when Penthienate is combined with GW842166. |
| Diphemanil | The risk or severity of Tachycardia and drowsiness can be increased when Diphemanil is combined with GW842166. |
| Camylofin | The risk or severity of Tachycardia and drowsiness can be increased when Camylofin is combined with GW842166. |
| Fenpiverinium | The risk or severity of Tachycardia and drowsiness can be increased when Fenpiverinium is combined with GW842166. |
| Emetonium iodide | The risk or severity of Tachycardia and drowsiness can be increased when Emetonium iodide is combined with GW842166. |
| Pipenzolate | The risk or severity of Tachycardia and drowsiness can be increased when Pipenzolate is combined with GW842166. |
| Timepidium | The risk or severity of Tachycardia and drowsiness can be increased when Timepidium is combined with GW842166. |
| Chlorphenoxamine | The risk or severity of Tachycardia and drowsiness can be increased when Chlorphenoxamine is combined with GW842166. |
| Phentermine | The risk or severity of Tachycardia can be increased when GW842166 is combined with Phentermine. |
| Midodrine | The risk or severity of Tachycardia can be increased when GW842166 is combined with Midodrine. |
| Norepinephrine | The risk or severity of Tachycardia can be increased when GW842166 is combined with Norepinephrine. |
| Phenylephrine | The risk or severity of Tachycardia can be increased when GW842166 is combined with Phenylephrine. |
| Phenylpropanolamine | The risk or severity of Tachycardia can be increased when GW842166 is combined with Phenylpropanolamine. |
| Labetalol | The risk or severity of Tachycardia can be increased when GW842166 is combined with Labetalol. |
| Metaraminol | The risk or severity of Tachycardia can be increased when GW842166 is combined with Metaraminol. |
| Epinephrine | The risk or severity of Tachycardia can be increased when GW842166 is combined with Epinephrine. |
| Methoxamine | The risk or severity of Tachycardia can be increased when GW842166 is combined with Methoxamine. |
| Orciprenaline | The risk or severity of Tachycardia can be increased when GW842166 is combined with Orciprenaline. |
| Phenmetrazine | The risk or severity of Tachycardia can be increased when GW842166 is combined with Phenmetrazine. |
| Dobutamine | The risk or severity of Tachycardia can be increased when GW842166 is combined with Dobutamine. |
| Pseudoephedrine | The risk or severity of Tachycardia can be increased when GW842166 is combined with Pseudoephedrine. |
| Ritodrine | The risk or severity of Tachycardia can be increased when GW842166 is combined with Ritodrine. |
| Terbutaline | The risk or severity of Tachycardia can be increased when GW842166 is combined with Terbutaline. |
| Oxymetazoline | The risk or severity of Tachycardia can be increased when GW842166 is combined with Oxymetazoline. |
| Dopamine | The risk or severity of Tachycardia can be increased when GW842166 is combined with Dopamine. |
| Isoprenaline | The risk or severity of Tachycardia can be increased when GW842166 is combined with Isoprenaline. |
| Acebutolol | The risk or severity of Tachycardia can be increased when GW842166 is combined with Acebutolol. |
| Lisdexamfetamine | The risk or severity of Tachycardia can be increased when GW842166 is combined with Lisdexamfetamine. |
| Fenoterol | The risk or severity of Tachycardia can be increased when GW842166 is combined with Fenoterol. |
| Ephedrine | The risk or severity of Tachycardia can be increased when GW842166 is combined with Ephedrine. |